CytoDyn (CYDY) Net Cash Flow (2010 - 2026)

CytoDyn's Net Cash Flow history runs 17 years deep, the most recent figure standing at $10.7 million for Q1 2026.

• Quarterly Net Cash Flow rose 316.27% year-over-year to $10.7 million in Q1 2026, while the trailing twelve-month figure through Feb 2026 was -$745000.0 (down 108.89% YoY) and the FY2025 annual result came in at $2.1 million, up 172.72% from the prior year.
• Net Cash Flow was $10.7 million for Q1 2026 at CytoDyn, up from -$4.4 million in the prior quarter.
• Across five years, Net Cash Flow topped out at $15.1 million in Q3 2024 and bottomed at -$6.5 million in Q1 2022.
• A 5-year average of $397058.8 and a median of -$1.8 million in 2023 frame the typical range for Net Cash Flow.
• Annual changes were most pronounced in 2024 — Net Cash Flow soared 3273.74% — and 2025, when it slumped 479.91%.
• CytoDyn's Net Cash Flow stood at -$2.1 million in 2022, then grew by 10.85% to -$1.8 million in 2023, then slumped by 94.05% to -$3.6 million in 2024, then declined by 21.31% to -$4.4 million in 2025, then surged by 345.36% to $10.7 million in 2026.
• Business Quant data shows CYDY's Net Cash Flow at $10.7 million in Q1 2026, -$4.4 million in Q4 2025, and -$2.6 million in Q3 2025.